WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN): payments to doctors

Payments that named WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN) as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.

The per-transaction average — $1,215 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 391 providers the average total is $3,055, but that average hides a very steep distribution.